International Journal of Cardiology
Volume 129, Issue 3 , Pages 339-343 , 13 October 2008

Sildenafil therapy in complex pulmonary atresia with pulmonary arterial hypertension

Received 4 July 2007 ,Accepted 18 August 2007.

References 

  1. Galiè N, Torbicki A, Barst R, et al. Task Force. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J. Dec 2004;25(24):2243–2278
  2. Humbert M, Sitbon O, Chaouat A, et al. Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med. May 1 2006;173(9):1023–1030
  3. Fyler DC. Report of the New England regional infant cardiac program. Pediatrics. 1980;65(suppl.):376–461
  4. Leonard H, Derrick G, O'Sullivan J, Wren C. Natural and unnatural history of pulmonary atresia. Heart. 2000;84:499–503
  5. Reddy VM, McElhinney DB, Amin Z, et al. Early and intermediate outcomes after repair of pulmonary atresia with ventricular septal defect and major aortopulmonary collateral arteries: experience with 85 patients. Circulation. Apr 18 2000;101(15):1826–1832
  6. Mair DD, Puga FJ. Management of pulmonary atresia with ventricular septal defect. Curr Treat Options Cardiovasc Med. Oct 2003;5(5):409–415
  7. Tantini B, Manes A, Fiumana E, et al. Antiproliferative effect of sildenafil on human pulmonary artery smooth muscle cells. Basic Res Cardiol. Mar 2005;100(2):131–138[Electronic publication 2004 Nov 24]
  8. Michelakis E, Tymchak W, Lien D, Webster L, Hashimoto K, Archer S. Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: comparison with inhaled nitric oxide. Circulation. May 21 2002;105(20):2398–2403
  9. Gyurko R, Kuhlencordt P, Fishman MC, et al. Modulation of mouse cardiac function in vivo by eNOS and ANP. Am J Physiol. 2000;278:H971–H981
  10. Weimann J, Ullrich R, Hromi J, et al. Sildenafil is a pulmonary vasodilator in awake lambs with acute pulmonary hypertension. Anesthesiology. 2000;92:1702–1712
  11. Lim ZS, Salmon AP, Vettukattil JJ, Veldtman GR. Sildenafil therapy for pulmonary arterial hypertension associated with atrial septal defects. Int J Cardiol. May 31 2007;118(2):178–182
  12. Thiene G, Frescura C, Bini RM, Valente M, Gallucci V. Histology of pulmonary arterial supply in pulmonary atresia with ventricular septal defect. Circulation. Nov 1979;60(5):1066–1074
  13. Hopkins SR, Johnson EC, Richardson RS, Wagner H, De Rosa M, Wagner PD. Effects of inhaled nitric oxide on gas exchange in lungs with shunt or poorly ventilated areas. Am J Respir Crit Care Med. Aug 1997;156(2 Pt 1):484–491
  14. Walmrath D, Schermuly R, Pilch J, Grimminger F, Seeger W. Effects of inhaled versus intravenous vasodilators in experimental pulmonary hypertension. Eur Respir J. May 1997;10(5):1084–1092
  15. Hirata K, Adji A, Vlachopoulos C, O'Rourke MF. Effect of sildenafil on cardiac performance in patients with heart failure. Am J Cardiol. Nov 15 2005;96(10):1436–1440

☆ All authors declare that the answer to the questions on your competing interest form are all no and therefore have nothing to declare.

PII: S0167-5273(07)01677-4

doi: 10.1016/j.ijcard.2007.08.016

International Journal of Cardiology
Volume 129, Issue 3 , Pages 339-343 , 13 October 2008

Article Tools

* Image Usage & Resolution